<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02876341</url>
  </required_header>
  <id_info>
    <org_study_id>16081002</org_study_id>
    <nct_id>NCT02876341</nct_id>
  </id_info>
  <brief_title>Effects of Chronic Antihypertensive Therapy on Clinical Outcomes in Septic Shock</brief_title>
  <official_title>Evaluating the Effect of Chronic Antihypertensive Therapy on New Onset Atrial Fibrillation and Clinical Outcomes in Septic Shock</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rush University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rush University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective two-cohort study to determine the effect of chronic antihypertensive therapy on
      new onset atrial fibrillation and clinical outcomes in septic shock.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a retrospective two-cohort study to determine the effect of chronic
      antihypertensive therapy on new onset atrial fibrillation and clinical outcomes in septic
      shock. The two cohorts will be septic shock patients that were: 1) not on either a chronic
      β-blocker or angiotensin-converting-enzyme inhibitor (ACE inhibitor) or 2) on a chronic
      β-blocker, on chronic ACE-Inhibitor, or on both chronic β-blocker and ACE-inhibitor
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2016</start_date>
  <completion_date type="Actual">March 31, 2017</completion_date>
  <primary_completion_date type="Actual">February 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative percent (%) of patients with new onset atrial fibrillation at 48 hours</measure>
    <time_frame>48 hours</time_frame>
    <description>New onset atrial fibrillation defined as atrial fibrillation not present on admission to MICU</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate &gt; 100</measure>
    <time_frame>48 hours</time_frame>
    <description>Total number of times with heart rate greater than 100 in 48 hours.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New onset of other arrhythmias</measure>
    <time_frame>48 hours</time_frame>
    <description>Total onset of other arrhythmias not present on admission. Examples include, ventricular fibrillation, ventricular tachycardia, heart blocks, etc</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak lactate</measure>
    <time_frame>48 hours</time_frame>
    <description>Peak lactate level during the first 48 hours of admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation</measure>
    <time_frame>During admission</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In hospital mortality</measure>
    <time_frame>During admission</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>28 day mortality</measure>
    <time_frame>28 days after discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>90 day mortality</measure>
    <time_frame>90 days after discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New onset atrial fibrillation for patients on other antiarrhythmics</measure>
    <time_frame>24 and 48 hours</time_frame>
    <description>Antiarrhythmic agents that are used to suppress abnormal rhythms of the heart (cardiac arrhythmias), such as atrial fibrillation, atrial flutter, ventricular tachycardia, and ventricular fibrillation. Will include any single or combination of class I, II, III, IV antiarrhythmic agents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative percent (%) of patients with new onset atrial fibrillation at 24 hours</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">133</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>No chronic antihypertensives</arm_group_label>
    <description>Not on either a chronic β-blocker or ACE-Inhibitor</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chronic antihypertensives</arm_group_label>
    <description>On a chronic β-blocker, on chronic ACE-Inhibitor, or on both chronic β-blocker and ACE-inhibitor</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adult, non pregnant medical intensive care (MICU) patient's with septic shock
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients 18 years of age or older

          -  Diagnosis of septic shock requiring vasopressor therapy (norepinephrine, epinephrine,
             phenylephrine, dopamine, or vasopressin)

          -  Admitted to the medical intensive care unit (MICU) at Rush University Medical Center
             (RUMC)

          -  Time frame: 01/01/2012 to 07/1/2016

        Exclusion Criteria:

          -  Pregnant patients

          -  Transfer from outside hospital on vasopressors

          -  Admitted to MICU in cardiopulmonary arrest

          -  Prior arrest within 24 hours of admission to RUMC
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joshua DeMott, Pharm.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rush University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ishaq Lat, Pharm.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rush University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gourang Patel, Pharm.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rush University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rush Univeristy Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 12, 2016</study_first_submitted>
  <study_first_submitted_qc>August 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 23, 2016</study_first_posted>
  <last_update_submitted>April 11, 2017</last_update_submitted>
  <last_update_submitted_qc>April 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic antihypertensives</keyword>
  <keyword>New onset atrial fibrillation</keyword>
  <keyword>Septic shock</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antihypertensive Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>To be determined</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

